Observational studyJournal of patient-reported outcomes2025

Health-related quality of life outcomes among vedolizumab-treated patients with inflammatory bowel disease in the UK and Ireland: a 52-week observational study (OCTAVO).

Gareth Parkes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.